Online citations, reference lists, and bibliographies.
← Back to Search

Expression Of Peptidylarginine Deiminase Type 4 (PAD4) In Various Tumors

X. Chang, Jinxiang Han
Published 2006 · Biology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Peptidylarginine deiminase type 4 (PAD4/PADI4) posttranslationally converts peptidylarginine to citrulline, in a process known as citrullination. Evidence suggests that PAD4 plays an essential role in pathogenesis of rheumatoid arthritis (RA). RA synovium has many features in common with tumor tissues, including abnormal cell proliferation, extensive fibrin deposition, high coagulation activity, and extreme angiogenesis. The purpose of the present study was to investigate expression of PAD4 in various tumor tissues. Immunohistochemistry indicated that PAD4 had significant expression in many tumor tissues, especially various adenocarcinoma. Western blotting with anti PAD4 antibody and immunostaining with anti citrulline antibody confirmed the expression of the enzyme in these tumors. Furthermore, our immunohistochemistry also detected co‐location of PAD4 with cytokeratin (CK), a well‐known tumor marker for oncological study in many tumors. Western blot analysis also detected citrulline signals in CK extracted from the tumors. In addition, CK 8, 18, and 19 following in vitro citrullination resisted to the digestion of caspase. The results further confirm the expression of PAD4 in the tumors and support that PAD4 may contribute to the disrupted apoptosis of tumors by caspase‐mediated cleavage of CK. Double immunofluorescent labeling detected co‐location of PAD4 with CD34, a cell marker of heamatopoietic progenitor cells (HPC) in bone marrow and other normal tissues, as well as in some fibroblast‐like cells at stroma region of tumors, but not in the tumor cells. The findings imply that PAD4 is initially expressed in CD34+ cells of bone marrow and then distributed in derives of the multi‐potent progenitor cells in diverse tissues. The development of tumor cells expressing PAD4 is possibly associated with abnormal proliferation of CD34+ stem cells. © 2005 Wiley‐Liss, Inc.
This paper references
Malignant melanoma. Interaction with coagulation and fibrinolysis pathways in situ.
M. Wojtukiewicz (1990)
Anticoagulants in cancer treatment: malignancy as a solid phase coagulopathy.
L. Zacharski (2002)
Keratin expression in human tissues and neoplasms
P. Chu (2002)
Expression of intermediate filament proteins in fetal and adult human lung tissues.
J. Broers (1989)
Coagulation proteases and human cancer.
M. T. Sampson (2002)
Functional haplotypesof PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis
A Suzuki (2003)
Thrombin increases the metastatic potential of tumor cells
M. Wojtukiewicz (1993)
Immunohistochemical localization of coagulation, fibrinolytic and antifibrinolytic markers in adenocarcinoma of the lung
B. Nakstad (1991)
Effect of Mutation and Phosphorylation of Type I Keratins on Their Caspase-mediated Degradation*
N. Ku (2001)
[Cytokeratin expression of benign and malignant epithelial thyroid gland tumors. An immunohistologic study of 154 neoplasms using 8 different monoclonal cytokeratin antibodies].
S. Schroeder (1996)
Immunocytochemical localization of peptidylarginine deiminase in human eosinophils and neutrophils
H. Asaga (2001)
CD34 positive stromal cells in gastric adenocarcinomas.
H. Nakayama (2001)
Keratin modifications and solubility properties in epithelial cells and in vitro.
M. Omary (1998)
Fibrinogen deposition and macrophage-associated fibrin formation in malignant and nonmalignant lymphoid tissue.
V. Costantini (1992)
Cytokeratins as markers of differentiation in the diagnosis of epithelial tumors.
R. Moll (1998)
Fibrinogen-fibrin transformation in situ in renal cell carcinoma.
M. Wojtukiewicz (1990)
The inhibition of antithrombin by peptidylarginine deiminase 4 may contribute to pathogenesis of rheumatoid arthritis.
X. Chang (2005)
Inhibition of antithrombin by hyaluronic acid may be involved in the pathogenesis of rheumatoid arthritis
X. Chang (2005)
Localization of peptidylarginine deiminase 4 (PADI4) and citrullinated protein in synovial tissue of rheumatoid arthritis.
X. Chang (2005)
Haemostatic Changes; Plasma Levels of Alpha2-Antiplasmin-Plasmin Complex and Thrombin-Antithrombin III Complex in Female Breast Cancer
Ö. Özyılkan (1998)
CD34+ or CD34−: which is the more primitive?
M. Engelhardt (2002)
Steroid hormone receptor in pleural solitary fibrous tumours and CD34+ progenitor stromal cells
M. Bongiovanni (2002)
The Versatility of Cytokeratins asTumor Markers
T. Stigbrand (2000)
Mechanism of thrombin-induced angiogenesis.
M. Maragoudakis (2002)
Distribution of cytokeratins, vimentin and desmoplakins in normal renal tissue, renal cell carcinomas and oncocytoma as revealed by immunofluorescence microscopy
A. Beham (2005)
Selective deimination of vimentin in calcium ionophore-induced apoptosis of mouse peritoneal macrophages.
H. Asaga (1998)
On the Mechanism of Thrombin-induced Angiogenesis
N. Tsopanoglou (1999)
Clinical utility of cytokeratins as tumor markers.
V. Barak (2004)
Apoptosis and keratin intermediate filaments
R. Oshima (2002)
Effects of human bone marrow stroma on the growth of human tumor cells.
E. Strobel (1989)
The versatility of cytokeratins as tumormarkers
T. Stigbrand (2001)
Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages.
E. Vossenaar (2004)
Use of monoclonal antibodies to keratin 7 in the differential diagnosis of adenocarcinomas.
F. Ramaekers (1990)
Serum antithrombin III and alpha-2-antiplasmin concentration in patients with lung carcinoma.
M. Dabrowska (1988)
Small cell carcinoma of the lung: macrophage-specific antigens suggest hemopoietic stem cell origin.
M. Ruff (1984)
Cellular origin of hepatocellular carcinomas.
S. Sell (2002)
Zytokeratinexpression benigner und maligner epithelialer Schilddrüsentumoren Eine immunhistologische Untersuchung an 154 Neoplasien unter Einsatz von 8 verschiedenen monoklonalen Zytokeratinantikörpern*
S. Schröder (1996)
The distribution and role of myofibroblasts and CD34-positive stromal cells in normal pancreas and various pancreatic lesions.
N. Kuroda (2004)
Lessons from disorders of epidermal differentiation-associated keratins.
A. Ishida-Yamamoto (2002)
Molecular Characterization of Peptidylarginine Deiminase in HL-60 Cells Induced by Retinoic Acid and 1α,25-Dihydroxyvitamin D3 *
K. Nakashima (1999)
Ca2+-dependent deimination-induced disassembly of intermediate filaments involves specific modification of the amino-terminal head domain.
M. Inagaki (1989)
Citrullination of fibronectin in synovial tissue of rheumatoid arthritis
X Chang (2005)
Tissue factor, thrombin, and cancer.
F. Rickles (2003)
PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease
E. Vossenaar (2003)
Cytokeratins in different types of human lung cancer as monitored by chain-specific monoclonal antibodies.
J. Broers (1988)
Thrombin enhances the adhesion and migration of human colon adenocarcinoma cells via increased beta 3-integrin expression on the tumour cell surface and their inhibition by the snake venom peptide, rhodostomin.
H. S. Chiang (1996)
Citrullination of fibronectin in rheumatoid arthritis synovial tissue.
X. Chang (2005)
Stem cells: A minireview
K. Jackson (2002)
Increased plasma thrombomodulin in cancer patients.
A. Lindahl (1993)
Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis
A. Suzuki (2003)
Colorimetric determination of citrulline residues in proteins.
K. Sugawara (1998)
Citrullinated proteins have increased immunogenicity and arthritogenicity and their presence in arthritic joints correlates with disease severity
K. Lundberg (2005)
CD34-positive stromal cells in primary lung carcinomas.
H. Nakayama (2003)
Endothelial CD34 is suppressed in human malignancies: role of angiogenic factors.
S. Hellwig (1997)
Haemostatic changes; plasma levels of alpha2-antiplasmin-plasmin complex and thrombin-antithrombin III complex in female breast cancer.
O. Ozyilkan (1994)
Fibrin deposition in squamous cell carcinomas of the larynx and hypopharynx.
H. Bárdos (1998)

This paper is referenced by
Synovial detection and autoantibody reactivity of processed citrullinated isoforms of vimentin in inflammatory arthritides.
K. Tilleman (2008)
Anti-Citrulline Antibodies in the Diagnosis and Prognosis of Rheumatoid Arthritis: Evolving Concepts
A. Raptopoulou (2007)
Specific expression of PAD4 and citrullinated proteins in lung cancer is not associated with anti-CCP antibody production.
Z. Baka (2011)
Investigating the Pathogenic Role of PADI4 in Oesophageal Cancer
X. Chang (2011)
B-cell specific Moloney leukemia virus insert site 1 and peptidyl arginine deiminase IV positively regulate carcinogenesis and progression of esophageal squamous cell carcinoma.
W. Wang (2017)
Progression of NETs Correlating with Tumor-Related Diseases.
Le-meng Zhang (2015)
Suppression of colitis in mice by Cl-amidine: a novel peptidylarginine deiminase inhibitor.
A. Chumanevich (2011)
Ongoing Studies of Deimination in Neurodegenerative Diseases Using the F95 Antibody
A. Nicholas (2014)
Citrullination under physiological and pathological conditions.
Z. Baka (2012)
Endogenous PAD4 in Breast Cancer Cells Mediates Cancer Extracellular Chromatin Network Formation and Promotes Lung Metastasis
L. Shi (2020)
Development of a fluorescent probe for detection of citrulline based on photo-induced electron transfer.
Kazuki Kunieda (2018)
The Induction of microRNA-16 in Colon Cancer Cells by Protein Arginine Deiminase Inhibition Causes a p53-Dependent Cell Cycle Arrest
Xiangli Cui (2013)
Anti-Citrullinated Protein Antibodies as Novel Therapeutic Drugs in Rheumatoid Arthritis
R. G. Chirivi (2013)
Substrate specificity and kinetic studies of PADs 1, 3, and 4 identify potent and selective inhibitors of protein arginine deiminase 3.
B. Knuckley (2010)
Protein-bound citrulline and homocitrulline in rheumatoid arthritis : confounding features arising from structural homology
S. Turunen (2014)
Extracellular vesicles from cod (Gadus morhua L.) mucus contain innate immune factors and deiminated protein cargo.
B. Magnadóttir (2019)
Guanidine-modifying enzymes in the pentein superfamily
Thomas W. Linsky (2010)
Inhibition of PCSK6 May Play a Protective Role in the Development of Rheumatoid Arthritis
Feifei Wang (2015)
Protein arginine methylation in estrogen signaling and estrogen-related cancers
C. Teyssier (2010)
Immune response signatures of benzo{alpha}pyrene exposure in normal human mammary epithelial cells in the absence or presence of chlorophyllin.
Kaarthik John (2009)
Transcriptional Regulation
A. Vancura (2012)
Expression of Peptidylarginine Deiminase Type 4 in Ovarian Tumors
L. Wang (2010)
Quantification of citrullinated histones: Development of an improved assay to reliably quantify nucleosomal H3Cit in human plasma
C. Thålin (2020)
Downregulation of the Deiminase PADI2 Is an Early Event in Colorectal Carcinogenesis and Indicates Poor Prognosis
Neus Cantariño (2016)
Potential Role of Peptidylarginine Deiminase Enzymes and Protein Citrullination in Cancer Pathogenesis
Sunish Mohanan (2012)
NETosis proceeds by cytoskeleton and endomembrane disassembly and PAD4-mediated chromatin de-condensation and nuclear envelope rupture
Hawa Racine Thiam (2019)
Extracellular matrix remodeling: the common denominator in connective tissue diseases. Possibilities for evaluation and current understanding of the matrix as more than a passive architecture, but a key player in tissue failure.
M. Karsdal (2013)
of nuclear GSK 3 Q : 4 β activates TGF-β signaling and induces EMT in breast cancer cells
Sonja C. Stadlera (2013)
Evaluation of autoimmune disease as a risk factor for lymphoma
B. Fowler (2013)
PAD4 inhibitors: potential sensitizers of tumour cells to TRAIL-induced apoptosis
Henna Khalid (2016)
The Deimination of Arginine to Citrulline
Andrew J Creese (2016)
Decreased PADI4 mRNA Association with Global Hypomethylation in Hepatocellular Carcinoma During HBV Exposure
C. Zhang (2012)
See more
Semantic Scholar Logo Some data provided by SemanticScholar